Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biogen

130.65
-1.6600-1.25%
Post-market: 130.650.00000.00%19:59 EDT
Volume:1.21M
Turnover:158.19M
Market Cap:19.14B
PE:12.92
High:132.49
Open:130.87
Low:130.11
Close:132.31
Loading ...
May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2025

Major Issues Report

Form 8-K - Current report
May 06, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 12, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2025

Major Issues Report

Form 8-K - Current report
Jan 15, 2025

Major Issues Report

Form 8-K - Current report
Dec 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 30, 2024

Major Issues Report

Form 8-K - Current report
Oct 30, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2024

Major Issues Report

Form 8-K - Current report
Oct 16, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 12, 2024

Major Issues Report

Form 8-K - Current report
Sep 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 15, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]